Top Markets
#1 Black Phoenix Black Phoenix +356.69%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +62.32%
#4 Gold Park Gold Park +57.04%
#5 Acurast Acurast +36.39%
#6 OpenEden OpenEden +29.86%
#7 BasedHype BasedHype +26.83%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.30%
#9 Cryptopia Cryptopia +21.54%
#10 Wibx Wibx +16.66%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Lotus Pharmaceuticals, Inc. Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc.

LTUS
Clasificación en acciones #40779
Lotus Pharmaceuticals, Inc. currently has no substantial business activities.... Lotus Pharmaceuticals, Inc. currently has no substantial business activities. Headquartered in Nashville, Tennessee, the company previously focused on the development, production, and distribution of pharmaceutical products within the People's Republic of China.
Precio por acción
$0.003
Última sincronización: 2026-08-12
Capitalización bursátil
$82.31K
Cambio (1 día)
0.00%
Cambio (1 año)
-62.64%
País
US
Comercio Lotus Pharmaceuticals, Inc. (LTUS)

Categoría

Healthcare
Ratio P/B de Lotus Pharmaceuticals, Inc. (LTUS)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Lotus Pharmaceuticals, Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Lotus Pharmaceuticals, Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.6634 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0941 -
US